CONFERENCE COVERAGE SERIES
International Conference on Alzheimer's & Parkinson's Diseases 2011
Barcelona, Spain
09 – 13 March 2011
Barcelona: 10th AD/PD Conference Hosts a Shaken, Restive Field
The buzz that 2,711 scientists from 68 countries generated at AD/PD 2011 was remarkable for how it sounded opposing notes at equal volume...
Barcelona: Straight Talk From a Regulator on Trials in Parkinson’s
It’s the rare occasion that scientists get unvarnished advice from their colleagues at the drug approval authorities at public conferences...
Barcelona: Taking Parkinson’s Research From Movement to Mind
Scientists are becoming increasingly aware of what Parkinson’s disease does to the mind...
Barcelona: What Lies Beyond Genomewide Association Studies?
The common late-onset forms of Alzheimer’s and Parkinson’s disease are now believed to involve substantial inherited risk...
Barcelona: Stocking Biomarker Arsenal for Lewy Body Dementia
Dementia with Lewy bodies (DLB) sits at the interface of several disorders...
Barcelona: Out of Left Field—Hit to The Eye Kills BACE Inhibitor
Whatever happened to BACE inhibitors?...
Barcelona: Live and Learn—γ-Secretase Inhibitors Fade, Modulators Rise
Scientists appear to be losing faith in the concept of Notch-sparing γ-secretase inhibition...
Barcelona: Allosteric γ Modulation Moves Toward Clinic
As the research field’s collective eyes are shifting toward the γ-secretase modulators, what do scientists actually have on that score?...
Barcelona: Is Parkinson’s Pathology Treatable?
For Parkinson’s disease, unlike Alzheimer’s, physicians have numerous effective treatments to reduce symptoms and improve their patients’ quality of life...
Barcelona: Parkinson’s Treatments on the Horizon
With effective symptomatic treatments in hand, many Parkinson’s researchers have now set their sights on loftier goals...
Barcelona: Antibody to Sweep Up Aβ Protofibrils in Human Brain
Better AD treatments are urgently needed, and a decade of setbacks in the clinic has left researchers searching for new ideas...
Barcelona: A Fistful of Schemes for Tackling Alzheimer’s
As scientists continue to pursue disease-modifying treatments for Alzheimer’s disease, various forms of oligomers have become the target du jour...
Barcelona: Inflammation—That Two-Faced Beast
Inflammation is common in neurodegenerative diseases, but scientists are not yet sure how it relates to pathology...